A new study indicates that certain GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers. In their study, the scientists reported that the direct effect of the GLP-1 drugs ...
SurvivorNet on MSN
CELMoDs: The next-generation drugs that could replace Revlimid in myeloma treatment
Right now, CELMoDs are being studied in patients whose cancer has returned after prior treatment, but their role could expand ...
Add Yahoo as a preferred source to see more of our stories on Google. Pharma companies are rushing to get the next generation of weight-loss drugs to market. Ozempic, which has become synonymous with ...
Multiple clinical trials have shown that GLP-1s are safe and effective for patients with obesity, diabetes and cardiovascular ...
Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population. Despite their effectiveness, they have drawbacks. Their effect may not last ...
Researchers have created a next-generation obesity drug that works like a “Trojan horse,” using GLP-1/GIP signals to slip a ...
KELOWNA, BC / ACCESS Newswire / April 23, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX), (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce the ...
First-Generation Antipsychotic Drugs By Jonathan Scheff This table lists selected first-generation antipsychotic drugs. For a table of atypical agents, click here. For a table of the next generation ...
ATLANTA -- A novel PCSK9 inhibitor safely reduced LDL cholesterol levels with just a single, quick, once-monthly dose, the phase III LIBerate-HR trial showed. Lerodalcibep reduced LDL cholesterol by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results